Myocardial ischemia alters immunoregulatory cell traffic and function in the rat independent of exogenous catecholamine administration

Journal of Neuroimmunology

Volumn 71, Issue 1-2, 1996, Pages 107-113

  Murray, David R ^b   Polizzi, Susan M ^c   Harris, Tamara J ^a   Maisel, Alan S ^a  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

adrenergic; catecholamines; immune cells; myocardial ischemia

Indexed keywords

CATECHOLAMINE; ISOPRENALINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HEART MUSCLE ISCHEMIA; IMMUNOREGULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE SUBPOPULATION;

ADRENERGIC BETA-AGONISTS; ANIMALS; CATECHOLAMINES; ISOPROTERENOL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MYOCARDIAL ISCHEMIA; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; T-LYMPHOCYTES; THORACOTOMY;

EID: 2642694385     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00138-5     Document Type: Article

References (23)

1. Bourne H.R., Lichtenstein L.M., Melmon K.L., Henney C.S., Weinstein Y., Shearer G.M. Modulation of inflammation and immunity by cAMP: receptors for vasoactive hormones and mediators of inflammation regulate many leukocyte functions. Science. 184:1974;19-28.
2. 125I) iodocyano-pindolol. Life Sci. 29:1981;2189-2198.
3. Crary B., Borysenko M., Sutherland D.C., Kutz I., Borysenko J.Z., Benson H. Decrease in mitogen responsiveness of mononuclear cells from peripheral blood after epinephrine administration in humans. J Immunol. 130:1983;694-697.
4. Crary B., Hauser S.L., Borysenko M., Kutz I., Hoban C., Ault K.A., Weiner H.L., Benson H. Epinephrine-induced changes in the distribution of lymphocyte subsets in peripheral blood of humans. J. Immunol. 131:1983;1178-1181.
5. Cunnick J.E., Lysle D.T., Kucinski B.J., Rabin B.S. Evidence that shock-induced immune suppression is mediated by adrenal hormones and peripheral β-adrenergic receptors. Pharmacol. Biochem. Behav. 36:1990;645-651.
6. Felten D.L., Felten S.Y., Bellinger D.L., Carlson S.L., Ackerman K.D., Madden K.S., Olschowski J.A., Livnat S. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol. Rev. 100:1987;22-260.
7. Feldman R.D., Hunninghake G.W., McArdle W.L. β-adrenergic receptor-mediated suppression of interleukin 2 receptors in human lymphocytes. J. Immunol. 139:1987;3355-3359.
8. Irwin M., Hauger R.L., Brown M., Britton K.T. CRF activates autonomic nervous system and reduces natural killer cytotoxicity. Am. J. Physiol. 225:1988;R744-R747.
9. Irwin M., Hauger R.L., Jones L., Provencio M., Britton K.T. Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity. J. Pharmacol. Exp. Ther. 255:1990;101-107.
10. Kammer G.M. The adenylate cyclase-cAMP -protein kinase A pathway and regulation of immune response. Immunol. Today. 9:1988;222-229.
11. Kaufman H.S., Kritash V.I. Immunologic abnormalities associated with acute ischemic heart disease (a pilot study). Ann. Allergy. 63:1989;287-290.
12. Kennedy J., Zeigler M.G. A more sensitive and specific radioenzymatic assay for catechols. Life Sci. 47:1990;2143-2153.
13. Khan M.M., Sansoni P., Silverman E.D., Engleman E.G., Melmon K.L. Beta-adrenergic receptors on human suppressor, helper and cytolytic lymphocytes. Biochem. Pharmacol. 35:1986;1137-1142.
14. Landmann R.M.A., Muller F.B., Perini C., Wesp M., Erne P., Buhler F.R. Changes of immunoregulatory cells induced by psychological and physical stress: Relationship to plasma catecholamines. Clin. Exp. Immunol. 58:1984;127-135.
15. Maisel A.S., Motulsky H., Insel P. Externalization of β-adrenergic receptors promoted by myocardial ischemia. Science. 230:1985;183-186.
16. Maisel, A.S., Fowler, P., Rearden, A., Motulsky, H.J. and Michel, M.C. (1989) A new method for isolation of human lymphocyte subsets reveals differential regulation of β-adrenergic receptors by terbutaline treatment. Clin. Pharmacol. Ther. 46: 429-39.
17. Maisel A.S., Knowlton K.U., Fowler P., Rearden C.A., Ziegler M.G., Motulsky H.J., Insel P.A., Michel M.C. Adrenergic control of circulating lymphocyte subpopulations: effects of congestive heart failure, dynamic exercise, and terbutaline treatment. J. Clin. Invest. 85:1992;462-467.
18. Maisel A.S., Harris T., Rearden C.A., Michel M.C. Beta-adrenergic receptors in lymphocyte subsets after exercise. Circulation. 82:1990;2003-2010.
19. 2-adrenergic dependent mechanism. Circulation. 86:1992;203-213.
20. Schomig A. Catecholamines in myocardial ischemia: systemic and cardiac release. Circulation. 82((Suppl II)):1990;II-13-II-22.
21. Syrjala H., Surcel H.M., Ilonen J. Low CD4/CD8 T lymphocyte ratio in acute myocardial infarction. Clin. Exp. Immunol. 83:1991;326-328.
22. Uhley H.N., Leeds S.E., Kaufman H.S. T-lymphocytes in experimental myocardial infarction. Ann. Allergy. 45:1980;280-283.
23. 2-adrenergic, spleen-dependent process. Am. J. Physiol. 258:1990;E-191-E-202.